EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer’s Disease Patients

Johnny Gutierrez, Carolin Kurz, Cosme Sandoval, Rose Edmonds, Tobias Bittner, Robert Perneczky, Anne Biever

Journal of Alzheimer’s Disease · 2024

DOI: 10.3233/jad-240287 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Johnny Gutierrez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medicine, Genentech Inc., South San Francisco, CA, USA. Hauptthemen laut MEDLINE: Alzheimer Disease, Biomarkers, Complement System Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Studies comparing cerebrospinal fluid (CSF) and plasma complement proteins in Alzheimer’s disease (AD) patients versus healthy controls (HC) have yielded inconsistent results. Discrepancies in the preanalytical sample handling could contribute to the heterogeneity in the reported findings.

Objective

Using qualified immunoassays, we aimed at assessing the impact of preanalytical procedures on complement proteins in blood and CSF from AD patients and HCs.

Methods

We supplemented HC and AD CSF/plasma with complement stabilizers and measured the complement proteins C4a, C4, C3a, C3, Factor Bb and Factor B by immunoassay. We tested the impact of freeze-thaw (FT) cycles on fluid complement proteins.

Results

Most complement proteins were mildly impacted by FT cycles in plasma but not CSF, except for C3a which displayed greater sensitivity to FTs in CSF than in plasma. In CSF, the effect of FTs on C3a was reduced but not prevented by the supplementation with EDTA (±Futhan).

Conclusions

Our findings provide recommendations for CSF/plasma sample handling to ensure robust and reproducible complement biomarker analyses in AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBiomarkersComplement System ProteinsHumansMaleFemaleAgedMiddle AgedSpecimen HandlingImmunoassayAged, 80 and over

Stichwörter der Autor:innen

Alzheimer’s diseasecomplementneuroinflammation biomarkerspreanalytical handling

Substanzen

BiomarkersComplement System Proteins

Autor:innen und Institutionen

  • Department of Translational Medicine, Genentech Inc., South San Francisco, CA, USA.
  • Department of Psychiatry and Psychotherapy, University Hospital, LMU Munich, Munich, Germany.
  • German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
  • Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.
  • Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK.
  • Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, UK.

Zitieren

APA

Gutierrez, J., Kurz, C., Sandoval, C., Edmonds, R., Bittner, T., Perneczky, R., & Biever, A. (2024). Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer’s Disease Patients. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-240287

Vancouver

Gutierrez J, Kurz C, Sandoval C, Edmonds R, Bittner T, Perneczky R, et al. Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer’s Disease Patients. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-240287

BibTeX
@article{Gutierrez2024,
  author = {Gutierrez, Johnny and Kurz, Carolin and Sandoval, Cosme and Edmonds, Rose and Bittner, Tobias and Perneczky, Robert and Biever, Anne},
  title = {Impact of Preanalytical Procedures on Complement Biomarkers in Cerebrospinal Fluid and Plasma from Controls and Alzheimer’s Disease Patients},
  journal = {Journal of Alzheimer’s Disease},
  year = {2024},
  doi = {10.3233/jad-240287}
}
Kostenlos starten →